James P Mackin
CIK 1408470 · President & CEO · last filed 2026-08-20
James P Mackin is a President & CEO who has filed 94 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider sold $2.0M of AORT on Aug 20, 2026. Across all open-market trades the lifetime net is −$30.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $30.4M across reported positions. 78 SEC filings were submitted jointly with CRYOLIFE INC. 12 Form 144 notices of planned sales are also on file; the latest, for AORT on Aug 19, 2026, lists the filer as an officer.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AORT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1655 ROBERTS BLVD, NW
KENNESAW, GA 30144
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AORT | President & CEO | 877,275 | $18.68 | $16.38M | -$18.86M | 32 | 2026-08-20 |
| CRY | President & CEO | 333,647 | $12.62 | $4.21M | -$11.49M | 33 | 2021-05-04 |
| Wright Medical Group N.V. (WMGI) Delisted | Director | 11,720 | — | — | $0 | 1 | 2019-07-30 |
| Wright Medical Group N.V. (WMGIZ) Delisted | Director | 7,804 | — | — | $0 | 1 | 2018-07-26 |
| MDT | SVP & Pres CRDM | 97,790 | $100.29 | $9.81M | -$398.1K | 14 | 2010-11-02 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| MDT | Direct | 97,016 | 99.2% | 2010-11-02 |
| ESOP | 774 | 0.8% | 2010-11-02 | |
| Total | 97,790 | |||
| No longer reported | ||||
| by ESOP | 736 | — | last 2008-07-30 | |
Recent Filings
94 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-20 | AORT | Sell (S) | −70,000 | -$2.03M | EDGAR |
| 2026-08-19 | AORT | Notice (144) Officer · Planned Aug 19, 2026 Sold: Form 4 filed Aug 20, 2026 |
−70,000 | -$2.05M | EDGAR |
| 2026-03-04 | AORT | Mixed | +99,061 | -$675.7K | EDGAR |
| 2026-03-03 | AORT | Notice (144) Officer, Director · Planned Mar 3, 2026 Sold: Form 4 filed Mar 3, 2026 |
−17,887 | -$675.7K | EDGAR |
| 2026-03-03 | AORT | Sell (S) | −14,911 | -$567.0K | EDGAR |
| 2026-03-02 | AORT | Notice (144) Officer, Director · Planned Mar 2, 2026 Sold: Form 4 filed Mar 3, 2026 |
−14,911 | -$567.0K | EDGAR |
| 2026-02-25 | AORT | Mixed | +62,132 | -$1.29M | EDGAR |
| 2026-02-24 | AORT | Notice (144) Officer, Director · Planned Feb 24, 2026 Sold: Form 4 filed Feb 25, 2026 |
−13,936 | -$497.4K | EDGAR |
| 2026-02-23 | AORT | Notice (144) Officer, Director · Planned Feb 23, 2026 Sold: Form 4 filed Feb 25, 2026 |
−20,962 | -$787.9K | EDGAR |
| 2025-12-04 | AORT | Mixed10b5-1 Plan adopted Sep 2, 2025 |
— | -$489.8K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).